Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

GPT Healthcare IPO Subscribed 1.29 Times, Issue to Close Today

19 Mar 2024 , 10:33 AM

The GPT Healthcare Initial Public Offering (IPO) commenced its subscription on February 22 and is set to conclude today, February 26. On day 2, the issue has received 0.85 times subscription overall. Click here to subscribe the IPO.

As per BSE data, on day 3, the retail portion of GPT Healthcare IPO was oversubscribed 1.65 times, while the Non-Institutional Investors (NII) portion subscribed 1.94 times. However, the Qualified Institutional Buyers (QIB) subscribed 0.19 times only.

The IPO’s price band is set between ₹177 to ₹186 per equity share with a lot size of 80 equity shares and multiples thereof.

GPT Healthcare IPO secured ₹157.54 Crores from anchor investors on February 22, allocating 84,69,996 equity shares at ₹186 each.

The IPO allocation reserved not more than 50% for Qualified Institutional Buyers (QIB), at least 15% for Non-Institutional Investors (NII), and a minimum of 35% for retail investors.

GPT Healthcare Ltd operates ‘ILS Hospitals,’ a chain of mid-sized full-service hospitals, focusing on secondary and tertiary care. Between March 31, 2022, and March 31, 2023, the company’s Profit After Tax (PAT) declined by -6.37%, while revenue increased by 7.11%.

GPT Healthcare IPO Details: The IPO is valued at ₹525.14 Crore, with a fresh issue of ₹40 Crore and an offer-for-sale (OFS) of 26,082,786 equity shares, aggregating up to ₹485.14 Crore by investor selling shareholder, Banyan Tree Growth Capital II, LLC.

The net proceeds will be directed towards general corporate objectives, and partial or full repayment of existing loans obtained from banks and financial institutions.

GPT Healthcare Ltd is a prominent regional corporate healthcare provider in Eastern India, operating in three locations, offering more than 35 specializations and super specialties. 

Management and Operations: JM Financial Limited is the book running lead manager for GPT Healthcare IPO, and Link Intime India Private Ltd is the issue’s registrar.

For feedback and suggestions, write to us at editorial@iifl.com
 

Related Tags

  • Business news
  • GPT Healthcare IPO
  • IPO news
  • Top News
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.